Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
AMY-101 by Amyndas Pharmaceuticals for Kidney Transplant Rejection: Likelihood of Approval
AMY-101 is under clinical development by Amyndas Pharmaceuticals and currently in Phase I for Kidney Transplant Rejection. According to GlobalData,...
AMY-101 by Amyndas Pharmaceuticals for Glomerulonephritis: Likelihood of Approval
AMY-101 is under clinical development by Amyndas Pharmaceuticals and currently in Phase I for Glomerulonephritis. According to GlobalData, Phase I...
AMY-101 by Amyndas Pharmaceuticals for Glomerulonephritis: Likelihood of Approval
AMY-101 is under clinical development by Amyndas Pharmaceuticals and currently in Phase I for Glomerulonephritis. According to GlobalData, Phase I...